Blue Jet Healthcare [BLUEJET] vs Supriya Lifescience [SUPRIYA] Detailed Stock Comparison

Blue Jet Healthcare

Supriya Lifescience
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Blue Jet Healthcare wins in 9 metrics, Supriya Lifescience wins in 10 metrics, with 0 ties. Supriya Lifescience appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Blue Jet Healthcare | Supriya Lifescience | Better |
---|---|---|---|
P/E Ratio (TTM) | 32.06 | 33.17 | Blue Jet Healthcare |
Price-to-Book Ratio | 10.12 | 5.89 | Supriya Lifescience |
Debt-to-Equity Ratio | 1.76 | 0.54 | Supriya Lifescience |
PEG Ratio | 0.23 | -1.51 | Supriya Lifescience |
EV/EBITDA | 22.53 | 23.37 | Blue Jet Healthcare |
Profit Margin (TTM) | 29.35% | 26.16% | Blue Jet Healthcare |
Operating Margin (TTM) | 32.50% | 31.19% | Blue Jet Healthcare |
EBITDA Margin (TTM) | 32.50% | 31.19% | Blue Jet Healthcare |
Return on Equity | 26.93% | 18.86% | Blue Jet Healthcare |
Return on Assets (TTM) | 21.53% | 16.90% | Blue Jet Healthcare |
Free Cash Flow (TTM) | $-341.15M | $22.99M | Supriya Lifescience |
Dividend Yield | 0.11% | 0.27% | Supriya Lifescience |
1-Year Return | 34.11% | 28.78% | Blue Jet Healthcare |
Price-to-Sales Ratio (TTM) | 9.40 | 8.67 | Supriya Lifescience |
Enterprise Value | $111.82B | $58.32B | Blue Jet Healthcare |
EV/Revenue Ratio | 9.15 | 8.57 | Supriya Lifescience |
Gross Profit Margin (TTM) | 48.44% | 78.10% | Supriya Lifescience |
Revenue per Share (TTM) | $70 | $85 | Supriya Lifescience |
Earnings per Share (Diluted) | $20.64 | $22.11 | Supriya Lifescience |
Beta (Stock Volatility) | N/A | 0.18 | N/A |
Blue Jet Healthcare vs Supriya Lifescience Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Blue Jet Healthcare | 0.31% | -1.61% | 1.52% | -21.56% | -21.29% | 14.58% |
Supriya Lifescience | -0.31% | -1.07% | 10.51% | 1.22% | 0.21% | -3.06% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Blue Jet Healthcare | 34.11% | 69.72% | 69.72% | 69.72% | 69.72% | 69.72% |
Supriya Lifescience | 28.78% | 144.00% | 51.61% | 51.61% | 51.61% | 51.61% |
News Based Sentiment: Blue Jet Healthcare vs Supriya Lifescience
Blue Jet Healthcare
News based Sentiment: POSITIVE
The primary event of the month was Blue Jet Healthcare's strong performance on the NSE, indicated by a significant stock price increase. This positive movement suggests a strengthening investment case and improved prospects for the company, making it a noteworthy development for investors.
Supriya Lifescience
News based Sentiment: MIXED
October saw Supriya Lifescience secure a key regulatory certification, alongside positive insider activity, but these were countered by a significant decline in quarterly revenue and profit. This creates a mixed investment picture, balancing long-term potential with short-term concerns.
Performance & Financial Health Analysis: Blue Jet Healthcare vs Supriya Lifescience
Metric | BLUEJET | SUPRIYA |
---|---|---|
Market Information | ||
Market Cap | ₹115.10B | ₹62.35B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 579,949 | 452,364 |
90 Day Avg. Volume | 749,694 | 229,303 |
Last Close | ₹663.70 | ₹731.10 |
52 Week Range | ₹463.70 - ₹1,027.80 | ₹511.40 - ₹842.00 |
% from 52W High | -35.43% | -13.17% |
All-Time High | ₹1,027.80 (Jul 21, 2025) | ₹842.00 (Mar 31, 2025) |
% from All-Time High | -35.43% | -13.17% |
Growth Metrics | ||
Quarterly Revenue Growth | 1.18% | -0.10% |
Quarterly Earnings Growth | 1.41% | -0.22% |
Financial Health | ||
Profit Margin (TTM) | 0.29% | 0.26% |
Operating Margin (TTM) | 0.33% | 0.31% |
Return on Equity (TTM) | 0.27% | 0.19% |
Debt to Equity (MRQ) | 1.76 | 0.54 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹65.36 | ₹124.44 |
Cash per Share (MRQ) | ₹17.68 | ₹9.83 |
Operating Cash Flow (TTM) | ₹899.31M | ₹1.87B |
Levered Free Cash Flow (TTM) | ₹3.05B | ₹1.88B |
Dividends | ||
Last 12-Month Dividend Yield | 0.11% | 0.27% |
Last 12-Month Dividend | ₹1.00 | ₹1.80 |
Valuation & Enterprise Metrics Analysis: Blue Jet Healthcare vs Supriya Lifescience
Metric | BLUEJET | SUPRIYA |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 32.06 | 33.17 |
Forward P/E | 40.49 | 24.28 |
PEG Ratio | 0.23 | -1.51 |
Price to Sales (TTM) | 9.40 | 8.67 |
Price to Book (MRQ) | 10.12 | 5.89 |
Market Capitalization | ||
Market Capitalization | ₹115.10B | ₹62.35B |
Enterprise Value | ₹111.82B | ₹58.32B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 9.15 | 8.57 |
Enterprise to EBITDA | 22.53 | 23.37 |
Risk & Other Metrics | ||
Beta | N/A | 0.18 |
Book Value per Share (MRQ) | ₹65.36 | ₹124.44 |
Financial Statements Comparison: Blue Jet Healthcare vs Supriya Lifescience
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | BLUEJET | SUPRIYA |
---|---|---|
Revenue/Sales | ₹3.55B | ₹1.45B |
Cost of Goods Sold | ₹1.83B | ₹317.72M |
Gross Profit | ₹1.72B | ₹1.13B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹1.15B | ₹452.50M |
EBITDA | ₹1.29B | ₹543.75M |
Pre-Tax Income | ₹1.23B | ₹474.12M |
Income Tax | ₹316.90M | ₹126.22M |
Net Income (Profit) | ₹911.70M | ₹347.90M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | BLUEJET | SUPRIYA |
---|---|---|
Cash & Equivalents | ₹329.79M | ₹759.97M |
Total Current Assets | ₹10.06B | ₹4.37B |
Total Current Liabilities | ₹2.56B | ₹821.62M |
Long-Term Debt | ₹165.26M | ₹50.57M |
Total Shareholders Equity | ₹11.33B | ₹9.97B |
Retained Earnings | ₹10.98B | ₹7.82B |
Property, Plant & Equipment | ₹212.65M | ₹645.91M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | BLUEJET | SUPRIYA |
---|---|---|
Operating Cash Flow | ₹539.01M | N/A |
Capital Expenditures | ₹-514.91M | N/A |
Free Cash Flow | ₹-54.59M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | BLUEJET | SUPRIYA |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 579,949 | 452,364 |
Average Daily Volume (90 Day) | 749,694 | 229,303 |
Shares Outstanding | 173.47M | 80.48M |
Float Shares | 33.16M | 25.53M |
% Held by Insiders | 0.86% | 0.72% |
% Held by Institutions | 0.01% | 0.03% |
Dividend Analysis & Yield Comparison: Blue Jet Healthcare vs Supriya Lifescience
Metric | BLUEJET | SUPRIYA |
---|---|---|
Last 12-Month Dividend | ₹1.00 | ₹1.80 |
Last 12-Month Dividend Yield | 0.11% | 0.27% |
3-Year Avg Annual Dividend | ₹0.33 | ₹0.80 |
3-Year Avg Dividend Yield | 0.19% | 0.17% |
3-Year Total Dividends | ₹1.00 | ₹2.40 |
Ex-Dividend Date | Sep 17, 2024 | Sep 04, 2025 |